Subsequently, Achermann et al. (1999) identified the first human NR5A1 loss-of-function variant in a 46,XY individual with gonadal dysgenesis and adrenal insufficiency, establishing the gene as a key determinant of human sex development [11]. The gene discussed is NR5A1; the disease is gonadal dysgenesis.